ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in …
!["ProLynx PLX038 Clinical Trial"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-4032060.webp?resize=600%2C400&ssl=1)
!["ProLynx PLX038 Clinical Trial"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/pexels-photo-4032060.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in …
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA …